These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21179212)

  • 1. Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle.
    Takikita S; Schreiner C; Baum R; Xie T; Ralston E; Plotz PH; Raben N
    PLoS One; 2010 Dec; 5(12):e15239. PubMed ID: 21179212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Muscle-Specific Overexpression of PGC-1α Induces Fiber-Type Conversion through Enhanced Mitochondrial Respiration and Fatty Acid Oxidation in Mice and Pigs.
    Zhang L; Zhou Y; Wu W; Hou L; Chen H; Zuo B; Xiong Y; Yang J
    Int J Biol Sci; 2017; 13(9):1152-1162. PubMed ID: 29104506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.
    Fukuda T; Ahearn M; Roberts A; Mattaliano RJ; Zaal K; Ralston E; Plotz PH; Raben N
    Mol Ther; 2006 Dec; 14(6):831-9. PubMed ID: 17008131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Benefit of Autophagy Modulation in Pompe Disease.
    Lim JA; Sun B; Puertollano R; Raben N
    Mol Ther; 2018 Jul; 26(7):1783-1796. PubMed ID: 29804932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.
    Takikita S; Myerowitz R; Zaal K; Raben N; Plotz PH
    Mol Genet Metab; 2009 Apr; 96(4):208-17. PubMed ID: 19167256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the transcriptional coactivator PGC-1alpha in muscle refueling.
    Wende AR; Schaeffer PJ; Parker GJ; Zechner C; Han DH; Chen MM; Hancock CR; Lehman JJ; Huss JM; McClain DA; Holloszy JO; Kelly DP
    J Biol Chem; 2007 Dec; 282(50):36642-51. PubMed ID: 17932032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe disease.
    Farah BL; Madden L; Li S; Nance S; Bird A; Bursac N; Yen PM; Young SP; Koeberl DD
    FASEB J; 2014 May; 28(5):2272-80. PubMed ID: 24448824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy and lysosomes in Pompe disease.
    Fukuda T; Roberts A; Ahearn M; Zaal K; Ralston E; Plotz PH; Raben N
    Autophagy; 2006; 2(4):318-20. PubMed ID: 16874053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in skeletal muscle: implications for Pompe disease.
    Shea L; Raben N
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1(Suppl 1):S42-7. PubMed ID: 20040311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease.
    Raben N; Schreiner C; Baum R; Takikita S; Xu S; Xie T; Myerowitz R; Komatsu M; Van der Meulen JH; Nagaraju K; Ralston E; Plotz PH
    Autophagy; 2010 Nov; 6(8):1078-89. PubMed ID: 20861693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.
    Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B
    J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of mutant acid alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Pompe disease.
    Khanna R; Powe AC; Lun Y; Soska R; Feng J; Dhulipala R; Frascella M; Garcia A; Pellegrino LJ; Xu S; Brignol N; Toth MJ; Do HV; Lockhart DJ; Wustman BA; Valenzano KJ
    PLoS One; 2014; 9(7):e102092. PubMed ID: 25036864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of Autophagy in Pompe Disease.
    Do H; Meena NK; Raben N
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.
    Douillard-Guilloux G; Raben N; Takikita S; Ferry A; Vignaud A; Guillet-Deniau I; Favier M; Thurberg BL; Roach PJ; Caillaud C; Richard E
    Hum Mol Genet; 2010 Feb; 19(4):684-96. PubMed ID: 19959526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II).
    Lagalice L; Pichon J; Gougeon E; Soussi S; Deniaud J; Ledevin M; Maurier V; Leroux I; Durand S; Ciron C; Franzoso F; Dubreil L; Larcher T; Rouger K; Colle MA
    Acta Neuropathol Commun; 2018 Oct; 6(1):116. PubMed ID: 30382921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral gene therapy with IGF2-tagged GAA normalizes the skeletal muscle proteome in murine Pompe disease.
    Liang Q; Vlaar EC; Pijnenburg JM; Rijkers E; Demmers JAA; Vulto AG; van der Ploeg AT; van Til NP; Pijnappel WWMP
    J Proteomics; 2024 Jan; 291():105037. PubMed ID: 38288553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle.
    Leick L; Wojtaszewski JF; Johansen ST; Kiilerich K; Comes G; Hellsten Y; Hidalgo J; Pilegaard H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E463-74. PubMed ID: 18073319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle.
    Vainshtein A; Tryon LD; Pauly M; Hood DA
    Am J Physiol Cell Physiol; 2015 May; 308(9):C710-9. PubMed ID: 25673772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand..
    Raben N; Takikita S; Pittis MG; Bembi B; Marie SK; Roberts A; Page L; Kishnani PS; Schoser BG; Chien YH; Ralston E; Nagaraju K; Plotz PH
    Autophagy; 2007; 3(6):546-52. PubMed ID: 17592248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.